They will share updates on our innovative tech platforms and drug candidates, with a special focus on our ADC technologies. Dr. Chu will present "Exploring ADCs With Site-Specific Conjugation, DAR of 8 or 12, & Payloads with Dual Drugs to Turbocharge ADC Innovation," covering:
• “CHO-TEM” technology combining CHO Pharma’s glycan modification and T-E Meds’ “Drug Bundles.”
• Producing homogeneous ADCs with high DAR (8 or 12) and dual drugs.
• Straightforward manufacturing process with great reaction yield.
World ADC Asia, the premier ADC conference, gathers top industry leaders to discuss the future of ADC development. Join us in Korea!
